Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients-Reference-Cited by-同舟云学术

Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients

Published:2017-10-05 Issue:10 Volume:12 Page:e0186120
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chang Ji Young,Kim Seong-Eun^ORCID,Kim Tae Hun,Woo So-Youn,Ryu Min Sun,Joo Yang-Hee,Lee Ko Eun,Lee Jihyun,Lee Kang Hoon,Moon Chang Mo,Jung Hye-Kyung,Shim Ki-Nam,Jung Sung-Ae

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders;JA Adachi;Clin Infect Dis,2006

2. History of the development of rifampin;P Sensi;Review of Infectious Diseases,1983

3. Rifaximin systemic absorption in patients with ulcerative colitis;F Rizzello;Eur J Clin Pharmacol,1998

4. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers;JJ Descombe;Int J Clin Pharmacol Res,1994

5. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential;C Scarpignato;Chemotherapy,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-Term Primary Rifaximin Prophylaxis Has No Beneficial Role in Patients With Cirrhosis;American Journal of Therapeutics;2024-08-27

2. The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review;Clinical Microbiology Reviews;2023-12-20

3. Antibiotic resistance in patients with liver cirrhosis: Prevalence and current approach to tackle;World Journal of Clinical Cases;2023-11-06

4. Faecal microbiota transplant restores intestinal barrier function and augments ammonia metabolism in patients with cirrhosis: a randomised single-blind placebo-controlled trial;2023-07-13

5. Rifaximin may induce rifampicin resistance in coagulase‐negative staphylococci;Liver International;2023-07-04